Building Competency in Diabetes Education THE ESSENTIALS

BASAL-BOLUS INSULIN THERAPY | 12-108

http://www.novonordisk.ca/content/dam/Canada/AFFILIATE/www-novonordisk- ca/OurProducts/PDF/fiasp-product-monograph.pdf. 53. Heinemann, L. Variability of insulin absorption and insulin action (review). Diabetes Technol Ther 2002;4:673-82. 54. Sindelka G, Heinemann L, Berger M, et al. Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 1994;37:377-80. 55. Frick AD, Burger F, Scholtz H, et al. Time-action profile of insulin glulisine vs. regular human insulin and insulin lispro in obese subjects. Poster presented at: American Diabetes Association 64th Scientific Sessions. June 4-8, 2004; Orlando, Florida. 56. Mudaliar SR, Lindberg FA, Joyce M, et al. Insulin Aspart (B28 Asp-Insulin): A fast-acting analog of human insulin. Diabetes Care 1999;22:1501-6. 57. Braak EW, Woodworth JR, Bianchi R, et al. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care 1996;19:1437-40. 58. Jovanovic L, Giammattei J, Acquistapace, M. et al. Efficacy comparison between pre- prandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size. Clin Ther 2004;26:1492-7. 59. Rassam A, Burge M, Zeise T, et al. Optimal administration of Lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care 1999;22:133-6. 60. Wolpert H. The nuts and bolts of achieving end points with real-time continuous glucose monitoring. Diabetes Care 2008;31(Suppl 2):S146-S150. 61. Walsh J, Roberts R. New Criteria for Assessing the Accuracy of Blood Glucose Monitors Meeting, October 28, 2011. J Diabetes Sci Technol 2012;6:466-74. 62. Heise T, Hövelmann U, Brøndsted L, et al. Faster-acting insulin aspart: Earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart. Diabetes Obes Metab 2015;17:682-8. 63. Kaufman F (Ed). Medical Management of Type 1 Diabetes, 6th edn. Tools of therapy chapter. 2012 American Diabetes Association: Alexandria, VA. 64. Hedman CA, Lindstrom T, Arnqvist HJ. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes [Letter to the editor]. Diabetes Care 2001;24:1120-1. 65. Home PD, Lindholm A, Riis A, for the European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long-term blood glucose control in type